Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Amydis
AddedFeb 15, 2024
UpdatedJul 17, 2026
Amydis

Amydis

Series A

San Diego-based Amydis is a private pharma company innovating in amyloid protein disease detection.

HQ
San Diego, CA, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Founded in San Diego, Amydis is a privately-held pharmaceutical company with a core mission to innovate in the detection of diseases involving amyloid proteins. The company's vision is to revolutionize precision healthcare by leveraging AI-powered technology. Amydis specializes in developing ocular tracers that facilitate the digital detection and monitoring of disease-related molecular biomarkers through standard ocular imaging cameras. Their market focus includes diseases of the eye, heart, and brain.

Notable affiliated people include experts in pharmaceutical development and AI technology, though specific names are not mentioned. Amydis has achieved significant milestones in pioneering ocular biomarker detection, positioning itself as a leader in this niche field. The impact of their work is substantial, offering new avenues for early and precise disease diagnosis, thereby potentially improving patient outcomes and advancing the field of precision medicine.

Amydis - Similar Companies

Adrx logo

Adrx

adrxpharma.com

Amylyx Pharmaceuticals logo

Amylyx Pharmaceuticals

amylyx.com

ADM Diagnostics logo

ADM Diagnostics

admdx.com

Diamir logo

Diamir

diamirbio.com

Autonomous Medical Devices logo

Autonomous Medical Devices

amdilabs.com

Ampel Biosolutions logo

Ampel Biosolutions

Amprion logo

Amprion

Amygdala Neurosciences logo

Amygdala Neurosciences

amygns.com

Amplified Sciences logo

Amplified Sciences

Attralus logo

Attralus

attralus.com

Darmiyan logo

Darmiyan

darmiyan.com

MediPrint Ophthalmics logo

MediPrint Ophthalmics

AltPep logo

AltPep

altpep.com

AI Therapeutics logo

AI Therapeutics

FYR Diagnostics logo

FYR Diagnostics

fyrdiagnostics.com

Amydis - Quick Facts

Who are Amydis' competitors?

Companies similar to Amydis include Adrx, Amylyx Pharmaceuticals, ADM Diagnostics and Diamir.

When was Amydis founded?

Amydis was founded in 2013.

Where is Amydis' headquarters located?

Amydis' headquarters is located in San Diego, CA, US.

When was Amydis' last funding round?

Amydis' most recent funding round was for $3.4M (USD) in November 2023.

How much has Amydis raised to-date?

As of Nov 14, 2023, Amydis has raised a total of $19.6M (USD).

How many employees does Amydis have?

Amydis has 41 employees as of Feb 5, 2024.

Amydis - Classification

Technology
  • AI
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified